119 related articles for article (PubMed ID: 21220985)
1. Unexpected detection of nodular melanoma of the skin on the scalp by I-123 IBZM brain SPECT.
Booij J; Boot E; van Eeden S; van Amelsvoort T
Clin Nucl Med; 2011 Feb; 36(2):148-9. PubMed ID: 21220985
[TBL] [Abstract][Full Text] [Related]
2. Differential accumulation of iodine-123-iodobenzamide in melanotic and amelanotic melanoma metastases in vivo.
Larisch R; Schulte KW; Vosberg H; Ruzicka T; Müller-Gärtner HW
J Nucl Med; 1998 Jun; 39(6):996-1001. PubMed ID: 9627332
[TBL] [Abstract][Full Text] [Related]
3. Scintigraphic detection of melanoma metastases with a radiolabeled benzamide ([iodine-123]-(S)-IBZM).
Maffioli L; Mascheroni L; Mongioj V; Gasparini M; Baldini MT; Seregni E; Castellani MR; Cascinelli N; Buraggi GL
J Nucl Med; 1994 Nov; 35(11):1741-7. PubMed ID: 7965150
[TBL] [Abstract][Full Text] [Related]
4. [Diagnostic value of 123iodine-ibzm scintigraphy for staging of malignant melanomas].
Henker C; Bida B; Markwardt J; Schlag P
Nuklearmedizin; 1997 Jan; 36(1):1-6. PubMed ID: 9082335
[TBL] [Abstract][Full Text] [Related]
5. Limited sensitivity of iodine-123-2-hydroxy-3-iodo-6-methoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl ] benzamide whole-body scintigraphy in patients with malignant melanoma: a comparison with thallium-201 imaging.
Brenner W; Klomp HJ; Bohuslavizki KH; Szonn B; Kampen WU; Henze E
Eur J Nucl Med; 1999 Dec; 26(12):1567-71. PubMed ID: 10638408
[TBL] [Abstract][Full Text] [Related]
6. Utility of SPECT/CT in preoperative planning for sentinel lymph node biopsy in melanoma and head/neck carcinoma: three illustrative cases.
Roarke MC; Ram P; Nguyen BD
Clin Nucl Med; 2007 Jun; 32(6):464-5. PubMed ID: 17515756
[No Abstract] [Full Text] [Related]
7. [Cerebral SPECT with iodine-123 IBZM in patients with extrapyramidal system disorders: the evaluation of its sensitivity in therapy with dopaminergic drugs].
Hierholzer J; Castelli L; Cordes M; Schelosky L; Poewe W; Felix R
Radiol Med; 1996 Mar; 91(3):207-10. PubMed ID: 8628932
[TBL] [Abstract][Full Text] [Related]
8. SPECT/CT for sentinel lymph node mapping in head and neck melanoma.
Vermeeren L; Valdés Olmos RA; Klop WM; van der Ploeg IM; Nieweg OE; Balm AJ; van den Brekel MW
Head Neck; 2011 Jan; 33(1):1-6. PubMed ID: 20848414
[TBL] [Abstract][Full Text] [Related]
9. [Dopamine (D2) receptor SPECT with 123I-iodobenzamide (IBZM) in diagnosis of Parkinson syndrome].
Reiche W; Grundmann M; Huber G
Radiologe; 1995 Nov; 35(11):838-43. PubMed ID: 8657887
[TBL] [Abstract][Full Text] [Related]
10. Iodine-123-IBZM dopamine D2 receptor and technetium-99m-HMPAO brain perfusion SPECT in the evaluation of patients with and subjects at risk for Huntington's disease.
Ichise M; Toyama H; Fornazzari L; Ballinger JR; Kirsh JC
J Nucl Med; 1993 Aug; 34(8):1274-81. PubMed ID: 8326384
[TBL] [Abstract][Full Text] [Related]
11. In vivo SPECT imaging of CNS D-2 dopamine receptors: initial studies with iodine-123-IBZM in humans.
Kung HF; Alavi A; Chang W; Kung MP; Keyes JW; Velchik MG; Billings J; Pan S; Noto R; Rausch
J Nucl Med; 1990 May; 31(5):573-9. PubMed ID: 2140408
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of [123I]IBZM pinhole SPECT for the detection of striatal dopamine D2 receptor availability in rats.
Scherfler C; Scholz SW; Donnemiller E; Decristoforo C; Oberladstätter M; Stefanova N; Diederen E; Virgolini I; Poewe W; Wenning GK
Neuroimage; 2005 Feb; 24(3):822-31. PubMed ID: 15652317
[TBL] [Abstract][Full Text] [Related]
13. [123I]IBZM uptake in metastatic melanoma.
Maffioli LS; Mascheroni L; Clemente C; Baldini M; Castellani MR
J Nucl Biol Med (1991); 1993 Mar; 37(1):18-20. PubMed ID: 8329472
[TBL] [Abstract][Full Text] [Related]
14. Desmoplastic melanoma presenting with localized hair repigmentation.
Rahim RR; Husain A; Tobin DJ; Lawrence CM
Br J Dermatol; 2013 Dec; 169(6):1371-3. PubMed ID: 23869420
[No Abstract] [Full Text] [Related]
15. Comparison of iodine-123-epidepride and iodine-123-IBZM for dopamine D2 receptor imaging.
Leslie WD; Abrams DN; Greenberg CR; Hobson D
J Nucl Med; 1996 Oct; 37(10):1589-91. PubMed ID: 8862288
[TBL] [Abstract][Full Text] [Related]
16. [The determination of cerebral dopamine (D2) receptor density by using 123I-IBZM-SPECT in Parkinson disease patients].
Hierholzer J; Cordes M; Schelosky L; Barzen G; Poewe W; Henkes H; Keske U; Horowski R; Felix R
Rofo; 1992 Oct; 157(4):390-8. PubMed ID: 1391843
[TBL] [Abstract][Full Text] [Related]
17. Cerebral kinetics of the dopamine D(2) receptor ligand [(123)I]IBZM in mice.
Meyer PT; Salber D; Schiefer J; Cremer M; Schaefer WM; Kosinski CM; Langen KJ
Nucl Med Biol; 2008 May; 35(4):467-73. PubMed ID: 18482684
[TBL] [Abstract][Full Text] [Related]
18. Continuous intravenous infusion of iodine-123-IBZM for SPECT determination of human brain dopamine receptor occupancy by antipsychotic agent RWJ-37796.
Seibyl JP; Zea-Ponce Y; Brenner L; Baldwin RM; Krystal JH; Offord SJ; Mochoviak S; Charney DS; Hoffer PB; Innis RB
J Nucl Med; 1996 Jan; 37(1):11-5. PubMed ID: 8543979
[TBL] [Abstract][Full Text] [Related]
19. Marked reduction of striatal dopamine D2 receptors as detected by 123IBZM-SPECT in a Wilson's disease patient with generalized dystonia.
Schwarz J; Tatsch K; Vogl T; Kirsch CM; Trenkwalder C; Arnold G; Gasser T; Oertel WH
Mov Disord; 1992; 7(1):58-61. PubMed ID: 1532631
[TBL] [Abstract][Full Text] [Related]
20. Dopamine D2 receptor brain imaging in the neonatal period using 123I-IBZM SPECT.
Tranquart F; Saliba E; Zimmer L; Barantin L; Lanneau M; Guilloteau D; Baulieu JL
J Nucl Med; 1999 Dec; 40(12):2126-7. PubMed ID: 10616897
[No Abstract] [Full Text] [Related]
[Next] [New Search]
